Careers  |  Sign In  |  Register  |   Twitter

Early Chemotherapy Helpful in Treatment of Prostate Cancer

A new study sponsored by the National Cancer Institute and presented at the American Society of Clinical Oncology Annual Meeting has revealed that men with prostate cancer who were administered chemotherapy early on lived longer than those who did not receive early chemotherapy. An article published in The New York Times discusses the benefits of this regimen, along with the fear that is associated with chemotherapy’s side effects, and the difficulty in getting men to agree with this treatment option. The study, consisting of 790 men, found that the median life after chemotherapy for those men receiving treatment was 57.6 months, versus 44.0 months in the men who chose other treatments.

Read it in The New York Times.